Chicago-area cardiologist assumes role during NLA Scientific Sessions in Las Vegas
News Stories
JACKSONVILLE, Fla. (March 22, 2018) — The 2018 National Lipid Association Nominating Committee released its annual report and recommendations on Thursday.
Name: Top Stories
ORLANDO (March 10, 2018) – The ODYSSEY OUTCOMES trial results, announced today at the American College of Cardiology 67th Annual Scientific Sessions in Orlando, revealed the addition of alirocumab to maximally tolerated statin significantly reduced major adverse cardiovascular events (MACE) compared to those on maximally tolerated statin and placebo.
Name: Top Stories